These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 29777328

  • 1. A systematic review on the off-label use of montelukast in atopic dermatitis treatment.
    Chin WK, Lee SWH.
    Int J Clin Pharm; 2018 Oct; 40(5):963-976. PubMed ID: 29777328
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Leukotriene receptor antagonism may not be effective in atopic dermatitis treatment after all.
    Chin WK.
    J Clin Pharm Ther; 2018 Feb; 43(1):159-162. PubMed ID: 29114905
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast.
    Angelova-Fischer I, Tsankov N.
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):115-9. PubMed ID: 16200338
    [Abstract] [Full Text] [Related]

  • 6. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis.
    Yanase DJ, David-Bajar K.
    J Am Acad Dermatol; 2001 Jan; 44(1):89-93. PubMed ID: 11148482
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Therapeutic Hotline: Cysteinyl leukotriene receptor antagonist montelukast in the treatment of atopic dermatitis.
    Broshtilova V, Gantcheva M.
    Dermatol Ther; 2010 Jan; 23(1):90-3. PubMed ID: 20136913
    [Abstract] [Full Text] [Related]

  • 10. Montelukast treatment of moderate to severe atopic dermatitis in adults: a randomized, double-blind, placebo-controlled trial.
    Veien NK, Busch-Sørensen M, Stausbøl-Grøn B.
    J Am Acad Dermatol; 2005 Jul; 53(1):147-9. PubMed ID: 15965438
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Montelukast in the treatment of children with moderate-to-severe atopic dermatitis: a pilot study.
    Pei AY, Chan HH, Leung TF.
    Pediatr Allergy Immunol; 2001 Jun; 12(3):154-8. PubMed ID: 11473680
    [Abstract] [Full Text] [Related]

  • 14. [A leukotriene antagonist (montelukast) in the treatment of atopic dermatitis in pediatric patients].
    Concha del Río LE, Arroyave CM.
    Rev Alerg Mex; 2003 Jun; 50(5):187-91. PubMed ID: 14631590
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Emerging therapies for atopic dermatitis: The prostaglandin/leukotriene pathway.
    Yanes DA, Mosser-Goldfarb JL.
    J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S71-S75. PubMed ID: 29248523
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Montelukast is not effective in controlling allergic symptoms outside the airways: a randomised double-blind placebo-controlled crossover study.
    Lehtimäki L, Petäys T, Haahtela T.
    Int Arch Allergy Immunol; 2009 Mar; 149(2):150-3. PubMed ID: 19127072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.